Cerebral microbleeds and blood pressure abnormalities in Parkinson's disease

Kazuo Yamashiro1, Ryota Tanaka1, Yasushi Shimo1

  • 1Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.

Eneurologicalsci
|May 9, 2018
PubMed

Insights

Blood pressure abnormalities like orthostatic hypotension and supine hypertension in Parkinson's disease (PD) patients are linked to deep cerebral microbleeds (CMBs). This finding highlights a potential connection between specific blood pressure patterns and small vessel disease in PD.

Area of Science:

  • Neurology
  • Cardiology
  • Cerebrovascular Disease

Background:

  • Blood pressure abnormalities are common in Parkinson's disease (PD).
  • These abnormalities are associated with cerebrovascular conditions like white matter hyperintensities and carotid atherosclerosis.
  • Cerebral microbleeds (CMBs) are indicators of cerebral small vessel disease.

Purpose of the Study:

  • To investigate the association between blood pressure abnormalities and CMBs in PD patients.
  • To determine if specific blood pressure patterns (orthostatic hypotension, supine hypertension, nocturnal hypertension, non-dipping) correlate with CMB presence and location.

Main Methods:

  • 128 PD patients were assessed for supine and orthostatic blood pressures.
  • 24-hour ambulatory blood pressure monitoring was used to identify orthostatic hypotension (OH), supine hypertension (SH), nocturnal hypertension (NH), and non-dipping.
  • CMBs were detected and analyzed for location (deep/infratentorial, lobar, mixed).

Main Results:

  • CMBs were present in 10.2% of PD patients, with a median of 1 CMB.
  • The presence of both OH and SH was independently associated with a higher number of deep or infratentorial CMBs.
  • No association was found between NH or non-dipping and deep/infratentorial CMBs, nor between any blood pressure pattern and lobar CMBs.

Conclusions:

  • The combination of orthostatic hypotension and supine hypertension may be linked to deep or infratentorial CMBs in Parkinson's disease.
  • These findings suggest a specific relationship between certain blood pressure dysregulations and small vessel disease in the deep brain regions of PD patients.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...